ALABAMA COMPANY IS ON A MISSION TO IMPROVE CARE OF PEOPLE ADDICTED TO OPIOIDS IN AMERICA’S JAILS.
|By NaphCare Inc|
| | Company Profile | CorrectSource
As the opioid epidemic continues its grip on America, each day hundreds of people are booked into the jails addicted to these dangerous drugs. Deprived of access to illegal drugs, addicts soon begin the dangerous process of drug withdrawal in the jail. NaphCare, a Birmingham-based correctional healthcare company, is on a mission to improve care of people withdrawing from opioids in the jail.
NaphCare, which provides comprehensive healthcare to almost 30,000 patients every day in twenty-seven jails across the Country, has developed a better approach to managing opioid withdrawal in the jails. Brad McLane, the Chief Operating Officer for NaphCare, explains as follows: “The standard approach to managing opioid withdrawal in the jails is to monitor the patient as they go through withdrawal and administer medications to blunt symptoms. These patients can become very sick and can even be at risk of dying. Our approach to caring for these patients dramatically reduces the risks and symptoms associated with withdrawal. We have gone from patients who were too sick to get out of bed, to patients who are healthy and able to work with our healthcare professionals to tend to their other healthcare and mental health needs.”
Over a little more than a year, NaphCare has started its new approach to managing opioid withdrawal in ten jails across the country in Ohio, New Jersey, Florida, Nevada, California and Washington. This better approach to managing opioid withdrawal provides for administration of a taper of a drug called buprenorphine to patients who have sufficiently severe withdrawal symptoms. The result is that patients not only withdraw safely but without the severe sickness that often otherwise accompanies withdrawal.
Dr. Emily Feely, Chief Medical Officer for NaphCare, explains that NaphCare’s approach to treating opioid withdrawal stems from the medical community’s evolving thinking about its dangers: “Not long ago, medical schools taught that opioid withdrawal was not life threatening. Today we know better. Opioid withdrawal can result in dehydration and electrolyte imbalances that can become life threatening. We believe that the best approach is to prevent the symptoms that cause dehydration by administering a buprenorphine taper, rather than allowing symptoms to manifest and managing them afterward.”
For more information contact:
Brad McLane, Chief of Operations,
Office: (205) 536-8532
Cell: (202) 731-8515